MAHON PAUL A (CIK 1231589) reported 312 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-21). Recent activity: Buy UTHR (2,690 shares), Buy UTHR (5,610 shares), Sell UTHR (2,690 shares), Sell UTHR (502 shares), Sell UTHR (1,819 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 2,690 | $392,821 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 5,610 | $819,228 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 2,690 | $1.4M |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 502 | $261,057 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,819 | $947,773 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 787 | $410,817 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 850 | $444,366 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 192 | $100,548 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 940 | $493,735 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 400 | $210,554 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 120 | $63,265 |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 760 | $389,817 |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,300 | $1.2M |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,795 | $924,106 |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,360 | $701,665 |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,617 | $835,869 |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 780 | $403,994 |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 360 | $186,776 |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,308 | $682,118 |
| 2026-08-06 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 320 | $167,166 |
| 2026-07-16 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,300 | $1.2M |
| 2026-07-16 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 600 | $316,557 |
| 2026-07-16 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 120 | $63,577 |
| 2026-07-16 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 861 | $458,025 |
| 2026-07-16 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 800 | $426,352 |
Source: SEC Form 4 filings · as of 2026-08-21